Abstract
Benzocaine (BZC), is a local anesthetic widely used in topical formulations as well as in throat pastilles. A disadvantage is that the compound presents low aqueous solubility. The present work describes the preparation and characterization of an inclusion complex between BZC and β-cyclodextrin (β-CD), followed by cytotoxicity assays. The association constant (Ka) was calculated using solubility isotherms, at different temperatures, and an HPLC procedure, at room temperature, employing a reverse phase C18 column, with a mobile phase consisting of water/acetonitrile. Ka obtained with solubility isotherms at temperatures of 25, 35, and 45 °C were 229.8, 317.1, and 520.3 M−1, respectively. Employing HPLC, Ka was 38.0 M−1. The difference in the Ka value could be explained because HPLC analyses were conducted using organic solvent, which affected the host–guest interaction. Moreover, the continuous flow could have altered the degree of association of the drug with β-CD. The BZC/CD inclusion complex was characterized using infrared spectroscopy, thermogravimetry, and X-ray diffraction. Analysis showed a good agreement with literature, suggesting that the complex was established. Cytotoxicity assays using fibroblast V79 cells showed that BZC/CD formulation was not cytotoxic, demonstrating its potential to reduce the toxicity of the anesthetic. The assays demonstrated an effective interaction between BZC and CD, and that the inclusion complex was less toxic to V79 cells than the plain BZC, turning it a good alternative to decrease its toxicity when administered to patients.
Similar content being viewed by others
References
Brunton, L.L., Blumenthal, D.K., Murri, N., Dandan, R.H., Knollmann, B.C.: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12th edn. McGraw-Hill, New York (2011)
Pinto, L.M.A., Fraceto, L.F., Santana, M.H.A., Pertinhez, T.A., Oyama Junior, S., de Paula, E.: Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes. J. Pharm. Biomed. Anal. 39, 956–963 (2005)
Al-Marzouqi, A.H., Jobe, B., Dowaidar, A., Maestrelli, F., Mura, P.: Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes—comparison with conventional methods. J. Pharm. Biomed. Anal. 43, 566–574 (2006)
Yang, H., Parniak, M.A., Hillier, S.L., Rohan, L.C.: A thermodynamic study of the cyclodextrin—UC781 inclusion complex using a HPLC method. J. Incl. Phenom. Macrocycl. Chem. 72, 459–465 (2012)
Sancho, M.I., Gasull, E., Blanco, S.E., Castro, E.A.: Inclusion complex of 2-chlorobenzophenone with cyclomaltoheptaose (β-cyclodextrin): temperature, solvents effects and molecular modeling. Carbohydr. Res. 346, 1978–1984 (2011)
Buha, S.M., Baxi, G.A., Shrivastav, P.S.: Liquid chromatography study on atenolol-β-cyclodextrin inclusion complex. ISRN Anal. Chem. 2012, 1–8 (2012)
Carvalho, L.B., Pinto, L.M.A.: Formation of inclusion complexes and controlled release of atrazine using free or silica-anchored β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 74, 375–381 (2012)
Rodrigues, S.G., Chaves, I.S., Melo, N.F.S., de Jesus, M.B., Fraceto, L.F., Fernandes, S.A., de Paula, E., Freitas, M.P., Pinto, L.M.A.: Computational analysis and physico-chemical characterization of an inclusion compound between praziquantel and methyl-β-cyclodextrin for use as an alternative in the treatment of schistosomiasis. J. Incl. Phenom. Macrocycl. Chem. 70, 19–28 (2011)
Pérez-Garrido, A., Helguera, A.M., Cordeiro, M.N.D.S., Escudero, A.G.: QSPR modelling with the topological substructural molecular design approach: β-cyclodextrin complexation. J. Pharm. Sci. 98, 4557–4575 (2009)
Moraes, C.M., Abrami, P., de Paula, E., Braga, A.F., Fraceto, L.F.: Study of the interaction between S(-) bupivacaine and 2-hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 331, 99–106 (2007)
Araújo, D.R., Tsuneda, S.S., Cereda, C.M.S., Carvalho, F.D.G.F., Preté, P.S.C., Fernandes, S.A., Yokaichiya, F., Franco, M.K.K.D., Mazzaro, I., Fraceto, L.F., Braga, A.F.A., de Paula, E.: Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-β-cyclodextrin inclusion complex. Eur. J. Pharm. Sci. 33, 60–71 (2008)
Arantes, L.M., Scarelli, C., Marsaioli, A.J., de Paula, E., Fernandes, S.A.: Proparacaine complexation with β-cyclodextrin and p-sulfonic acid calix[6]arene, as evaluated by varied 1H-NMR approaches. Magn. Reson. Chem. 47, 757–763 (2009)
de Paula, E., Cereda, C.M.S., Tofoli, G.R., Franz-Montan, M., Fraceto, L.F., de Araujo, D.R.: Drug delivery systems for local anesthetics. Recent Pat. Drug Deliv. Formul. 4, 23–34 (2010)
Jug, M., Maestrelli, F., Bragagni, M., Mura, P.: Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. J. Pharm. Biomed. Anal. 52, 9–18 (2010)
Lima, R.A.F., Jesus, M.B., Cereda, C.M.S., Tofoli, G.R., Cabeça, L.F., Mazzaro, I., Fraceto, L.F., de Paula, E.: Improvement of tetracaine antinociceptive effect by inclusion in cyclodextrins. J. Drug Target. 20, 85–96 (2012)
Higuchi, T.E., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117–121 (1965)
Riddell, R.J., Panacer, D.S., Wilde, S.M., Clothier, R.H., Ball, M.: The importance of exposure period and cell type in in vitro cytotoxicity tests. Altern. Lab. Anim. 14, 86–92 (1986)
Dawoud, A.A., Al-Rawashdeh, N.: Spectrofluorometric, thermal, and molecular mechanics studies of the inclusion complexation of selected imidazoline-derived drugs with β-cyclodextrin in aqueous media. J. Incl. Phenom. Macrocycl. Chem. 60, 293–301 (2008)
Al-Rawashdeh, N.A.F., Al-Ajlouni, A.M., Bukallah, S.B., Bataineh, N.: Activation of H2O2 by methyltrioxorhenium(VII) inside β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 70, 471–480 (2011)
Gazpio, C., Sánches, M., García-Zubiri, I.X., Vélaz, I., Martínez-Ohárriz, C., Martín, C., Zornoza, A.: HPLC and solubility study of the interaction between pindolol and cyclodextrin. J. Pharm. Biomed. Anal. 37, 487–492 (2005)
Singh, R., Bharti, N., Madan, J., Hiremath, S.N.: Characterization of cyclodextrin inclusion complexes—a review. J. Pharm. Sci. Technol. 2, 171–183 (2010)
Silverstein, R.M., Webster, F.X., Kiemle, D.: Spectrometric Identification of Organic Compounds, 7th edn. Wiley, New York (2005)
Tsai, Y., Tsai, H.H., Wu, C.P., Tsai, F.J.: Preparation, characterization and activity of the inclusion complex of paeonol with β-cyclodextrin. Food Chem. 120, 837–841 (2010)
Garnero, C., Aiassa, V., Longhi, M.: Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization. J. Pharm. Biomed. Anal. 63, 74–79 (2012)
Mura, P., Furlanetto, S., Cirri, M., Maestrelli, F., Corti, G., Pinzauti, S.: Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. J. Pharm. Biomed. Anal. 37, 987–994 (2005)
Varghese, B., Suliman, F.O., Al-Hajri, A., Al Bishri, N.S.S., Al-Rwashda, N.: Spectral and theoretical study on complexation of sulfamethoxazole with β- and HPβ-cyclodextrins in binary and ternary systems. Spectrochim. Acta A 190, 392–401 (2018)
Acknowledgements
The authors thank Centro de Análises e Prospecção Química (CAPQ/UFLA), Departamento de Ciências do Solo (UFLA), and Laboratório de Cultura de Células (UNICAMP) for the provision of equipment and facilities. M.Z.C. received a fellowship from FAPEMIG, and L.M.A.P. received a fellowship from FAPESP.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
10847_2018_791_MOESM1_ESM.tif
Supplementary material 1 Decrease in BZC retention time in the presence of increasing concentrations of β-CD. Chromatographic conditions described in the methodology section (TIF 12 KB)
Rights and permissions
About this article
Cite this article
Torres, L.H., de Carvalho, M.Z., Melo, P.d.S. et al. Characterization and cytotoxicity of a benzocaine inclusion complex. J Incl Phenom Macrocycl Chem 91, 9–15 (2018). https://doi.org/10.1007/s10847-018-0791-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-018-0791-3